20% PROSOL 1.18 G / 100 ML
HISTIDINE : 1.18 G / 100 ML TYROSINE : 0.05 G / 100 ML ARGININE : 1.96 G / 100 ML GLUTAMIC ACID : 1.02 G / 100 ML LEUCINE : 1.08 G / 100 ML ALANINE : 2.76 G / 100 ML VALINE : 1.44 G / 100 ML ISOLEUCINE : 1.08 G / 100 ML GLYCINE : 2.06 G / 100 ML PHENYLALANINE : 1 G / 100 ML SERINE : 1.02 G / 100 ML L-ASPARTIC ACID : 0.6 G / 100 ML DL-METHIONINE : 0.76 G / 100 ML TRYPTOPHAN : 0.32 G / 100 ML THREONINE : 0.98 G / 100 ML LYSINE (LYSINE ACETATE) : 1.35 G / 100 ML PROLINE : 1.34 G / 100 ML · DIN 02141450 · BAXTER CORPORATION
Health Canada status: MARKETED
What is 20% PROSOL?
20% PROSOL 1.18 G / 100 ML contains HISTIDINE : 1.18 G / 100 ML TYROSINE : 0.05 G / 100 ML ARGININE : 1.96 G / 100 ML GLUTAMIC ACID : 1.02 G / 100 ML LEUCINE : 1.08 G / 100 ML ALANINE : 2.76 G / 100 ML VALINE : 1.44 G / 100 ML ISOLEUCINE : 1.08 G / 100 ML GLYCINE : 2.06 G / 100 ML PHENYLALANINE : 1 G / 100 ML SERINE : 1.02 G / 100 ML L-ASPARTIC ACID : 0.6 G / 100 ML DL-METHIONINE : 0.76 G / 100 ML TRYPTOPHAN : 0.32 G / 100 ML THREONINE : 0.98 G / 100 ML LYSINE (LYSINE ACETATE) : 1.35 G / 100 ML PROLINE : 1.34 G / 100 ML. It is listed in the Health Canada Drug Product Database under DIN 02141450, held by BAXTER CORPORATION, supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as marketed, status dated 23-Jan-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is 20% PROSOL used for?
Source of amino acids for treatment of negative nitrogen balance when oral/enteral nutrition is impossible, gastrointestinal absorption is impaired, or metabolic requirements are high.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02141450 |
|---|---|
| Brand name | 20% PROSOL |
| Generic / active ingredient | HISTIDINE : 1.18 G / 100 ML TYROSINE : 0.05 G / 100 ML ARGININE : 1.96 G / 100 ML GLUTAMIC ACID : 1.02 G / 100 ML LEUCINE : 1.08 G / 100 ML ALANINE : 2.76 G / 100 ML VALINE : 1.44 G / 100 ML ISOLEUCINE : 1.08 G / 100 ML GLYCINE : 2.06 G / 100 ML PHENYLALANINE : 1 G / 100 ML SERINE : 1.02 G / 100 ML L-ASPARTIC ACID : 0.6 G / 100 ML DL-METHIONINE : 0.76 G / 100 ML TRYPTOPHAN : 0.32 G / 100 ML THREONINE : 0.98 G / 100 ML LYSINE (LYSINE ACETATE) : 1.35 G / 100 ML PROLINE : 1.34 G / 100 ML |
| Manufacturer | BAXTER CORPORATION |
| Strength | 1.18 G / 100 ML |
| Dosage form | LIQUID |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05BA01 AMINO ACIDS |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 23-Jan-2015 |
| Original market date | 2004-04-12 00:00:00 |
How is it administered?
Pharmacy bulk pack; not for direct infusion. Adult dose: 1.0 to 1.5 g/kg/day. Infants: 2 to 3 g/kg/day. Adjust based on metabolic requirements. Gradual initiation/termination required.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store in overwrap. (Specific temperature range not explicitly stated in provided text, but standard for Viaflex is typically 15-30°C).
How is it supplied?
Viaflex plastic Pharmacy Bulk Package containers of 2000 mL.
Contraindications
Hypersensitivity; severe liver failure or hepatic coma; acute renal failure without renal replacement therapy; congenital abnormality of amino acid metabolism.
Warnings and precautions
Risk of precipitates (pulmonary vascular emboli); monitor for hyperammonemia, infection, and refeeding syndrome. High osmolarity requires dilution for peripheral use.
What can be used instead?
Other Canadian products sharing ATC code B05BA01 AMINO ACIDS. 4 of 26 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ESSEPNA | 1.1 G / 100 ML | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02510324 |
| PRIMENE 10% | 189 MG / 100 ML | LIQUID | BAXTER CORPORATION | MARKETED | DIN 02236875 |
| TRAVASOL | 600 MG / 100 ML | SOLUTION | BAXTER CORPORATION | MARKETED | DIN 00872296 |
| 4.25% AMINO ACID INJECTION WITHOUT ELECTROLYTES IN 20% DEXTROSE QUICKMIX | 76 MG / 100 ML | SOLUTION | BAXTER CORPORATION CLINTEC NUTRITION DIVISION | CANCELLED POST MARKET | DIN 02013908 |
| 8.5% FREAMINE III | 770 MG / 100 ML | LIQUID | B. BRAUN MEDICAL INC | CANCELLED POST MARKET | DIN 02158647 |
| AMINOSYN | 440 MG / 100 ML | SOLUTION | ICU MEDICAL CANADA INC | CANCELLED POST MARKET | DIN 00454907 |
| AMINOSYN 5% | 220 MG / 100 ML | SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00404160 |
| AMINOSYN 7% | 690 MG / 100 ML | SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00523232 |
| AMINOSYN 8.5% | 624 MG / 100 ML | SOLUTION | HOSPIRA HEALTHCARE ULC | CANCELLED POST MARKET | DIN 00613320 |
| AMINOSYN II | 172 MG / 100 ML | SOLUTION | ICU MEDICAL CANADA INC | DORMANT | DIN 00742619 |
Who else supplies AMINO ACIDS worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. AMINO ACIDS appears in 215 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.